1-3 of 3
Veit Schmelmer
Close
Sort by
Journal Articles

Mgta-145 + Plerixafor Provides GCSF-Free Rapid and Reliable Hematopoietic Stem Cell Mobilization for Autologous Stem Cell Transplant in Patients with Multiple Myeloma: A Phase 2 Study

Surbhi Sidana, Andriyana K Bankova, Hitomi Hosoya, Shaji Kumar, John Tamaresis, Anne Le, Lori Muffly, Laura J. Johnston, Sally Arai, Robert Lowsky, Everett H Meyer, Andrew R. Rezvani, Wen-Kai Weng, Matthew J. Frank, Parveen Shiraz, Douglas Girgenti, Kevin A. Goncalves, Veit Schmelmer, John C. Davis, Jr., Ying Lu, Judith A Shizuru, David B. Miklos
Journal: Blood
Blood (2021) 138 (Supplement 1): 3885.
https://doi.org/10.1182/blood-2021-149306
Published: 2021
Journal Articles

Mgta-145, in Combination with Plerixafor in a Phase 1 Clinical Trial, Mobilizes Large Numbers of Human Hematopoietic Stem Cells and a Graft with Immunosuppressive Effects for Allogeneic Transplant

Kevin A. Goncalves, PhD, Sharon L. Hyzy, MS, Katelyn J. Hammond, BS, Patrick C. Falahee, PhD, Haley Howell, BS, BA, Jan Pinkas, PhD, Veit Schmelmer, PhD, Jonathan G. Hoggatt, PhD, David T. Scadden, MD, Steven M Devine, MD, John F. DiPersio, MD PhD, Will J. Savage, MDPhD, John C. Davis, Jr., MD MPH, MS
Journal: Blood
Blood (2020) 136 (Supplement 1): 31–32.
https://doi.org/10.1182/blood-2020-142804
Published: 2020
Journal Articles

Rapid and Robust Mobilization of CD34+ HSCs without G-CSF Following Administration of Mgta-145 Alone or in Combination with Plerixafor

John F. DiPersio, MD PhD, Jonathan Hoggatt, PhD, Steven Devine, MD, Lukasz Biernat, MD, Haley Howell, BS, BA, Veit Schmelmer, PhD, Jason R. Neale, PhD, Anthony E. Boitano, PhD, Michael P. Cooke, PhD, Kevin A. Goncalves, PhD, Glen D. Raffel, MD PhD, Patrick C. Falahee, PhD, Dwight M. Morrow, PhD, John C. Davis, Jr., MD MPH, MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 1961.
https://doi.org/10.1182/blood-2019-127523
Published: 2019